Skip to main content
Fig. 3 | Alzheimer's Research & Therapy

Fig. 3

From: Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease

Fig. 3

a Plasma Aβ1–42 levels in amyloid PET− and PET+ APOE ε4 carriers and APOE ε4 non-carriers. b Plasma Aβ1–42 levels in amyloid PET− and PET+ APOE ε4 carriers and non-carriers. APOE ε4 non-carriers are divided into APOE ε2 carriers and non-carriers. The dashed and dotted lines are the plasma Aβ1–42 cut-off values, 18.68 pg/ml and 15.58 pg/ml, for differentiating PET− from PET+ in APOE ε4 carriers and non-carriers, respectively. Abbreviations: Aβ, Amyloid β; PET+, amyloid positron emission tomography positivity; PET−, amyloid positron emission tomography negativity

Back to article page